Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Real World Characterization of Advanced Non-Small Cell Lung Cancer in Never Smokers by Actionable Mutation Status.

Clinical lung cancer - 1 Jul 2021

Kerrigan Kathleen, Wang Xuechen, Haaland Benjamin, Adamson Blythe, Patel Shiven, Puri Sonam, Akerley Wallace

Abstract excerpt

BACKGROUND: Non-small cell lung cancer (NSCLC) in never-smokers (NS) is vastly different from those with a smoking history in terms of etiology, driver mutations, and immunotherapy responsiveness. This study compares the real-world overall survival (OS) of NSCLC patients by smoking history and mutation status. METHODS: The study included 30,310 advanced or metastatic NSCLC patients in the Flatiron Health...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Databases, Factual

Share to Follow-Up Studies

Share to Lung Neoplasms

Share to Smokers

Share to Smoking

Share to Survival Rate

Source

Identifiers

PMID: 33678584
DOI: 10.1016/j.cllc.2021.01.013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Real World Characterization of Advanced Non-Small Cell Lung Cancer in Never Smokers by Actionable Mutation Status.PMID 33678584Read ↗

Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma.Semantic proximity Read ↗

EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancerSemantic proximity Read ↗

Republished: lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?Semantic proximity Read ↗

Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas.Semantic proximity Read ↗

Lung cancer in never-smokers. Does smoking history matter in the era of molecular diagnostics and targeted therapy?Semantic proximity Read ↗

Comprehensive molecular profiling of squamous non-small cell lung cancer reveals high incidence of actionable genomic alterations among patients with no history of smoking.Semantic proximity Read ↗

Proportion and clinical features of never-smokers with non-small cell lung cancer.Semantic proximity Read ↗

Dearth of smoking-induced mutations in NSRO-driven non-small-cell lung cancer despite smoking exposureSemantic proximity Read ↗

Clinical characteristics of lung cancer in never-smokers: a multicenter Saudi cohort.Semantic proximity Read ↗

Former smokers with non-small-cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis.Semantic proximity Read ↗

Survival difference according to mutation status in a prospective cohort study of Australian patients with metastatic non-small-cell lung carcinoma.Semantic proximity Read ↗

Real-World Survival Outcomes in Non-Small Cell Lung Cancer: The Impact of Genomic Testing and Targeted Therapies in a Latin American Middle-Income Country.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.